We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EU Calls For Suspension Of J&J's Ionsys

Law360 (November 20, 2008, 12:00 AM EST) -- In a blow to Johnson & Johnson, the European Union's drug-regulating body has recommended suspending approval for the sale of Ionsys in Europe because of a defect with the pain medicine's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.